These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8184798)

  • 1. Transdermal estrogen and prevention of osteoporosis.
    Filer WD; Filer RB
    Am Fam Physician; 1994 May; 49(7):1639-44. PubMed ID: 8184798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of transdermal hormone substitution for postmenopausal osteoporosis].
    Felsenberg D
    Zentralbl Gynakol; 1995; 117(10):516-23. PubMed ID: 7491834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen replacement therapy and the estraderm transdermal system.
    Youngkin EQ
    Nurse Pract; 1990 May; 15(5):19-26, 31. PubMed ID: 2342664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
    Henzl MR; Loomba PK
    J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The importance of estradiol treatment by the transdermal route in preventing postmenopausal osteoporosis].
    Borrelli AL; Hoffmann M; Pecchillo MA; Iolascon G
    Clin Ter; 1992 Apr; 140(4):379-82. PubMed ID: 1587121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The smallest available estradiol transdermal patch: a new treatment option for the prevention of postmenopausal osteoporosis.
    Bertonazzi A; Nelson B; Salvador J; Umland E
    Womens Health (Lond); 2015 Nov; 11(6):815-24. PubMed ID: 26618621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B; Pressman A; Bradley C
    Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the dose of hormone replacement therapy.
    Rice VM
    Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery.
    Baker VL
    Obstet Gynecol Clin North Am; 1994 Jun; 21(2):271-97. PubMed ID: 7936545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulsed estrogen therapy: relieving climacteric symptoms, preventing postmenopausal bone loss.
    Palacios S
    Climacteric; 2002 Jun; 5 Suppl 2():32-9. PubMed ID: 12482109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
    Ettinger B; Pressman A
    Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle delivery for transdermal HRT.
    Valenzuela P; Simon JA
    Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women.
    Cacciatore B; Paakkari I; Hasselblatt R; Nieminen MS; Toivonen J; Tikkanen MI; Ylikorkala O
    Am J Obstet Gynecol; 2001 Apr; 184(5):904-9. PubMed ID: 11303197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy in postmenopausal women.
    Yasui T; Uemura H; Takikawa M; Irahara M
    J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on continuous estrogen-progestin replacement therapy.
    Rosenfeld JA
    Am Fam Physician; 1994 Nov; 50(7):1519-23, 1527-8. PubMed ID: 7976988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.